Monkeypox: Concern in Europe after case in Sweden

“The confirmation of Clade 1 mpox in Sweden clearly reflects the interconnectedness of our world (…) It is likely that more imported cases of Clade 1 will be recorded in the European region in the coming days and weeks,” stated the World Health Organization.

Nordic: We Can Prepare 10 Million Vaccines

Meanwhile, just hours after the WHO declared a high-alert status for monkeypox, the pharmaceutical company Bavarian Nordic announced that it is ready to produce 10 million doses of the vaccine by the end of 2025.

However, he quickly added that they would wait for orders from interested countries before scaling up vaccine production, saying, “We need to see the vaccines first.” Currently, the company claims to have a stockpile of 500,000 doses.

According to international media, the company’s stock, whose mpox vaccines have been licensed since 2019, rose by up to 8% on the Copenhagen stock exchange on Thursday, following a 12% increase on Wednesday.